What is Kyowa Kirin Co. Ltd?
engages in the research, development, manufacture, import/export, and market of pharmaceuticals products worldwide.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
engages in the research, development, manufacture, import/export, and market of pharmaceuticals products worldwide. The company offers Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; POTELIGEO for the treatment of cutaneous T-cell lymphoma; Nouriast/Nourianz, an adenosine A2A receptor antagonist; G-LASTA, a mobilization of hematopoietic stem cells into peripheral blood for autologous blood stem cell transplantation; Libmeldy/Lenmeldy for treating metachromatic leukodystrophy; Orkedia for treatment of secondary hyperparathyroidism; and Romiplate to treat aplastic anemia. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 9.63B, and a P/E ratio of 21.7x.
A short list of Drug Manufacturers - Specialty & Generic names that are close enough in size to make side-by-side comparison useful.